share_log

CG Oncology | SC 13G: Statement of acquisition of beneficial ownership by individuals-Xiangmin Cui(7.6%),Decheng Capital Global Life Sciences Fund IV, L.P.(6.9%), etc.

SEC announcement ·  Feb 8 17:21
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more